QIAGEN announced earlier in January plans for the repurchase, which comes after QIAGEN returned approximately $300 million to shareholders in early 2024 also through a synthetic share repurchase.

The value of Qiagen's common shares will be increased through a transfer from the share premium reserve to allow for the capital repayment to shareholders, followed by a reverse stock split to ...

This new repurchase comes after QIAGEN returned approximately $300 million to shareholders in early 2024 through a synthetic share repurchase. Together, these two programs represent $600 million ...